OSLO, Norway, April 12, 2023 /PRNewswire/ -- Photocure ASA
today announces the publication of the Annual Report and integrated
ESG report for 2022.
The Board of Directors of Photocure ASA has approved the annual
accounts for 2022. The financial statements and annual report for
the financial year 2022 are together with the ESG report and
auditor's report attached to this notice. The ESEF file for 2022 is
also attached.
The documents are enclosed and also made available at the
company's website under
https://photocure.com/investors-hub/investors-events-and-presentations.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: +47 450 55 000
Email: ed@photocure.com
About Photocure ASA:
Photocure: The Bladder Cancer Company delivers transformative
solutions to improve the lives of bladder cancer patients. Our
unique technology, making cancer cells glow bright pink, has led to
better health outcomes for patients worldwide. Photocure is
headquartered in Oslo, Norway, and
listed on the Oslo Stock Exchange (OSE: PHO). For more information,
please visit us at www.photocure.com, www.hexvix.com or
www.cysview.com.
All trademarks mentioned in this release are protected by law
and are registered trademarks of Photocure ASA. This information is
subject to the disclosure requirements pursuant to sections 5-12 of
the Norwegian Securities Trading Act.
The following files are available for download:
|
https://mb.cision.com/Main/17498/3749645/1979906.pdf
|
Release
|
|
https://mb.cision.com/Main/17498/3749645/1979907.zip
|
Photocure ESEF report
2022.zip
|
|
https://mb.cision.com/Public/17498/3749645/a1982643aaacf296.pdf
|
Photocure Annual Report
and ESG 2022
|
View original
content:https://www.prnewswire.co.uk/news-releases/photocure-asa-annual-report-2022-301795682.html